PROPOFOL BAXTER 10 mg/ml, injectable emulsion/for infusion bottle, 100 ml
Active ingredients: Propofol
Commercialized according to BDPMDispensing in France: Prescription only, hospital use
Emulsion for infusionbottle, 100 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- PROPOFOL BAXTER 10 mg/ml, émulsion injectable/pour perfusion
- Pharmaceutical form
- émulsion injectable pour perfusion
- Route of administration
- intraveineuse
- Presentation description
- 1 flacon(s) en verre de 100 ml
- Marketing authorisation holder
- BAXTER HOLDING (PAYS-BAS)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 10 Apr 2020
- Prescription and dispensing conditions
- Prescription only, hospital use
- List I: prescription-only medicine
- Hospital use only
- Emergency use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63558577CIP75500175CIP133400955001751Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| PROPOFOLémulsion | 10 mg · 1 ml d'émulsion | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.